Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH.
Lassmann
Michael
M
Hänscheid
Heribert
H
Reiners
Christoph
C
Thomas
Stephen R
SR
D000284:Administration, Oral; D000368:Aged; D000369:Aged, 80 and over; D001822:Body Burden; D001853:Bone Marrow / Q000000981:diagnostic imaging* / Q000187:drug effects / Q000528:radiation effects*; D017024:Chemotherapy, Adjuvant; D006801:Humans; D007273:Injections, Intramuscular; D007457:Iodine Radioisotopes / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D011832:Radiation Injuries / Q000209:etiology / Q000517:prevention & control; D011835:Radiation Protection / Q000379:methods; D011874:Radiometry / Q000379:methods*; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D011879:Radiotherapy Dosage; D011994:Recombinant Proteins / Q000008:administration & dosage; D018570:Risk Assessment / Q000379:methods*; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000532:radiotherapy* / Q000556:secondary; D013972:Thyrotropin / Q000008:administration & dosage* / Q000235:genetics; D016896:Treatment Outcome
D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals; D011994:Recombinant Proteins; D013972:Thyrotropin